论文部分内容阅读
公司发布公告,近日公司研制的国家一类新药“艾瑞昔布片及原料”获得国家食品药品监督管理局(SFDA)颁发的《新药证书》及《药品注册批件》。
The company issued a public notice recently developed by the company a new national drug “Eriocephalo tablets and raw materials ” won the State Food and Drug Administration (SFDA) issued a “new drug certificate” and “drug registration approval document.”